Ginkgo Bioworks Holdings, Inc. vs. Twist Bioscience Corporation Common Stock
DNA
Ginkgo Bioworks Holdings, Inc.
$12.50 -2.57%
VS TWSTTwist Bioscience Corporation Common Stock
$188.67 +0.33%
Twist Bioscience Corporation Common Stock (TWST) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| DNA | TWST | |
|---|---|---|
| Market Cap | $863.98 million | $12.51 billion |
| Revenue (TTM) | $111.86 million | — |
| Net Income (TTM) | $-290,803,000 | — |
TWST leads on 1 of 1 size & scale factors.
Valuation
| DNA | TWST | |
|---|---|---|
| Price / Book | 2.06 | — |
| Price / Sales | 7.72 | — |
DNA and TWST split the valuation factors evenly.
Profitability
| DNA | TWST | |
|---|---|---|
| Net Margin | -259.96% | — |
| Return on Equity | -69.19% | — |
DNA and TWST split the profitability factors evenly.
Risk & Sentiment
| DNA | TWST | |
|---|---|---|
| Short Interest | 18.73% | 0.08% |
TWST leads on 1 of 1 risk & sentiment factors.
Dig deeper: DNA overview, DNA financials, TWST overview, TWST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.